Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1991; 66(04): 500-504
DOI: 10.1055/s-0038-1646446

Review Article

Schattauer GmbH Stuttgart

Detection of the Glanzmann's Thrombasthenia Mutations in Arab and Iraqi-Jewish Patients by Polymerase Chain Reaction and Restriction Analysis of Blood or Urine Samples

H Peretz

The Chemistry Laboratory and Institute of Hematology, Sourasky-Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel

Division of Hematology, State University of New York at Stony Brook, New York, and Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin, USA

,

U Seligsohn

The Chemistry Laboratory and Institute of Hematology, Sourasky-Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel

Division of Hematology, State University of New York at Stony Brook, New York, and Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin, USA

,

E Zwang

The Chemistry Laboratory and Institute of Hematology, Sourasky-Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel

Division of Hematology, State University of New York at Stony Brook, New York, and Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin, USA

,

B S Coller

The Chemistry Laboratory and Institute of Hematology, Sourasky-Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel

Division of Hematology, State University of New York at Stony Brook, New York, and Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin, USA

,

P J Newman

The Chemistry Laboratory and Institute of Hematology, Sourasky-Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel

Division of Hematology, State University of New York at Stony Brook, New York, and Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin, USA

› Author Affiliations

Summary

Severe Glanzmann's thrombasthenia is relatively frequent in Iraqi-Jews and Arabs residing in Israel. We have recently described the mutations responsible for the disease in Iraqi-Jews – an 11 base pair deletion in exon 12 of the glycoprotein IIIa gene, and in Arabs – a 13 base pair deletion at the AG acceptor splice site of exon 4 on the glycoprotein IIb gene. In this communication we show that the Iraqi-Jewish mutation can be identified directly by polymerase chain reaction and gel electrophoresis. With specially designed oligonucleotide primers encompassing the mutation site, an 80 base pair segment amplified in healthy controls was clearly distinguished from the 69 base pair segment produced in patients. Patients from 11 unrelated Iraqi-Jewish families had the same mutation. The Arab mutation was identified by first amplifying a DNA segment consisting of 312 base pairs in controls and of 299 base pairs in patients, and then digestion by a restriction enzyme Stu-1, which recognizes a site that is absent in the mutant gene. In controls the 312 bp segment was digested into 235 and 77 bp fragments, while in patients there was no change in the size of the amplified 299 bp segment. The mutation was found in patients from 3 out of 5 unrelated Arab families. Both Iraqi-Jewish and Arab mutations were detectable in DNA extracted from blood and urine samples. The described simple methods of identifying the mutations should be useful for detection of the numerous potential carriers among the affected kindreds and for prenatal diagnosis using DNA extracted from chorionic villi samples.

References
1 George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 1990; 75: 1383-95
2 Levy JM, Mayer G, Sacrez R, Ruff R, Francfort JJ, Rodier L. Trombasthenie de Glanzmann-Naegeli. Etude d'un groupe ethnique à forte endogamie. Sem Hop Paris 1971; 47: 129-37
3 Khanduri U, Pulimood R, Sudarsanam A, Carman RH, Jadhav M, Peirera S, Pulimood BM. Glanzmann's thrombasthenia: A review of 42 cases from South India. Thromb Haemostas 1981; 46: 717-21
4 Awidi AS. Increased incidence of Glanzmann thrombasthenia in Jordan as compared to Scandinavia. Scand J Haematol 1983; 30: 218-22
5 Seligsohn U, Rososhansky S. A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemostas 1984; 52: 230-1
6 Coller BS, Seligsohn U, Zivelin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations of Israel: Comparison of techniques for carrier detection. Br J Haematol 1986; 62: 723-35
7 Coller BS, Seligsohn U, Little PA. Type I Glanzmann thrombasthenia patients from the Iraqi Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood 1987; 69: 1696-703
8 Seligsohn U, Coller BS, Zivelin A, Plow EF, Ginsberg MH. Immunoblot analysis of platelet glycoprotein IIb in patients with Glanzmann thrombasthenia in Israel. Br J Haematol 1989; 72: 415-23
9 Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75-83
10 Poncz M, Eisman R, Heidenreich R, Silver SM, Vilaire G, Surrey S, Schwartz E, Bennett JS. Structure of the platelet membrane glycoprotein IIb. Homology to the a subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 1987; 262: 8476-82
11 Fitzgerald LA, Steiner B, Rall SC, Lo S-S, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". J Biol Chem 1987; 262: 3936-9
12 Heidenreich R, Eisman R, Surrey S, Delgrosso K, Bennett JS, Schwartz E, Poncz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry 1990; 29: 1232-44
13 Zimrin AB, Gidwitz S, Lord S, Schwartz E, Bennett JS, White GC, Poncz M. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990; 265: 8590-5
14 Newman PJ, Gorski J, White GC, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988; 82: 739-43
15 Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann's thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci (USA) 1991; 88: 3160-4
16 Miller SA, Dikes DD, Polesky HE. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: 1215
17 Gasparini P, Savoia A, Pignatti PF, Dallapiggola B, Novelli G. Amplification of DNA from epithelial cells in urine. N Engl J Med 1989; 320: 809
18 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91
19 Shore S, Myerowitz R. Polymerase chain reaction-generated heteroduplexes from Ashkenazi Tay-Sachs carriers with an insertion mutation can be detected on agarose gels. Am J Hum Genet 1990; 47: 169
20 Rommens J, Kerem B, Greer W, Chang P, Tsui LC, Ray P. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990; 46: 395-6
21 Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33-42
22 Coller BS, Folts JD, Smith SR, Scudder LE, Jordan R. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Circulation 1989; 80: 1766-74
23 Gold HK, Gimple LW, Yasuda T, Leinbach RC, Werner W, Holt R, Jordan R, Berger H, Collen D, Coller BS. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. J Clin Invest 1990; 86: 651-9